Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY20 results · Jan–Mar 2020
Amrutanjan Health Care reported revenue from operations of ₹59.29 crore (down 31.0% from Q4 FY19) and net profit of ₹7.89 crore (down 44.7% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a standalone basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 59.29 | 85.97 | −31.0% | 82.75 | −28.4% |
| Other income | 2.64 | 2.67 | −1.1% | 2.26 | +16.8% |
| Total income | 61.93 | 88.64 | −30.1% | 85.02 | −27.1% |
| Profit before tax | 10.64 | 20.20 | −47.3% | 12.60 | −15.6% |
| Net profit for the period | 7.89 | 14.27 | −44.7% | 9.49 | −16.9% |
| EPS, basic (₹) | 2.70 | 4.88 | −44.7% | 3.25 | −16.9% |
| Net margin (%) | 13.3 | 16.6 | 11.5 |
Standalone
- Filed with BSE
- 18 Jun 2020, 18:18 IST
- Board meeting
- 18 Jun 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE